Skip to main content

Drugs

Ausgabe 4/2024

Inhalt (12 Artikel)

Open Access Leading Article

The Pharmacological Landscape for Fatty Change of the Pancreas

Maxim S. Petrov

Open Access Review Article

Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?

Sanne M. Buijs, Stijn L. W. Koolen, Ron H. J. Mathijssen, Agnes Jager

Review Article

Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines

Congrui Zhu, Shengmei Pang, Jiaqi Liu, Qiangde Duan

Systematic Review

Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials

Yifan Wang, He Yi, Weixia Sun, Hekai Yu, Wenxuan Tao, Xiaojin Yu, Dianrong Jia, Yingzhao Liu, Stephen J. Pandol, Ling Li

Adis Drug Evaluation

Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease

Amy Zhuang-Yan, Yahiya Y. Syed

AdisInsight Report

Aponermin: First Approval

Sohita Dhillon

AdisInsight Report

Apadamtase Alfa: First Approval

Young-A. Heo

Open Access AdisInsight Report

Eplontersen: First Approval

Tina Nie

AdisInsight Report

Fidanacogene Elaparvovec: First Approval

Sohita Dhillon

Correction

Correction: Aponermin: First Approval

Sohita Dhillon

Open Access Correction

Correction: Eplontersen: First Approval

Tina Nie

Aktuelle Ausgaben